Report - Investor presentation - Reata Pharmaceuticals...2018/09/09  · 1ASN 2016 Poster FR-PO636 9 CARDINAL Phase 2 Baseline Characteristics Years Prior to CARDINAL Entry -3 -2 -1 Average

Please pass captcha verification before submit form